Prelude Therapeutics Incorporated filed its quarterly report on Form 10-Q with the SEC on November 16, 2026, covering the three and nine months ended September 30, 2026.
Instil Bio, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 16, 2026, disclosing a net loss of $4.231 million for the third quarter and $13.023 million for the nine months ended September 30, 2026.
Translational Development Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 16, 2026, reporting a net loss of $9,293,622 for the third quarter and disclosing a new $10,200,000 Subscription Agreement liability on its balance …
Xtend AI Robotics, Inc. filed a Form 8-K with the SEC on November 16, 2026, announcing its financial results for the quarter ended September 30, 2026, with the full press release furnished as Exhibit 99.1.
TheReversalfollowed a powerful run. The shares were up almost 5% over the past week and nearly 20% over the past month heading into Friday, and the broader market was also under pressure. AerCap's chief executive recently sold shares worth more than $9.4 million, a …
The gas market was the main headwind. U.S. natural gas futures fell about 3% to around $3.23 per million British thermal units after the Energy Information Administration reported a 61 billion cubic foot storage injection for the week ended November 6. That took Lower …
The stock is still working through its third-quarter report on November 9 and a round of price-target reductions on November 10. Mizuho cut its target to $9 from $11 while keeping an Outperform rating, Canaccord Genuity trimmed its target to $12 from $15 with …
The gain followed a tough week of analyst actions. On November 12, Bernstein downgraded Devon to Market Perform from Outperform, and Siebert Williams Shank cut its target to $61 from $71 while keeping a Buy rating. On November 10, UBS lowered its target to …
The gain also followed a downgrade earlier in the week. On November 12, Bernstein cut Diamondback to Market Perform from Outperform and lowered its target to $192 from $221, citing the risk that easing U.S.-Iran tensions could pressure oil prices and returns for oil …
Spot gold finished Friday at about $3,884.69 an ounce, up just 0.18% on the day but down roughly 4.6% from the prior Friday. Silver fell about 2.6% to under $49 an ounce after U.S. producer price data kept expectations of a December Federal Reserve …